about
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the ful...
Read More
14.43
0.31
(2.20%)
202.3K
XNAS Volume
XNAS 05 Sep, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for Septerna Inc. took place on 05 Sep 2025, for the purpose of 2025 Wells Fargo Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Septerna Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..